Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?

Shim, Myungsun; Bang, Woo Jin; Oh, Cheol Young; Lee, Yong Seong; Cho, Jin Seon

Shim, Myungsun; Bang, Woo Jin; Oh, Cheol Young; Lee, Yong Seong; Cho, Jin Seon.

Afiliação

Shim M; Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea.
Bang WJ; Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea.
Oh CY; Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea.
Lee YS; Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea.
Cho JS; Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea.

Prostate Int ; 10(1): 68-74, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35510099

Palavras-chave

AD, Alzheimer's disease; ADT, androgen deprivation therapy; Adverse effects; Androgen deprivation; Cognitive dysfunction; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulfate; DHT, dihydrotestosterone; Dementia; HR, hazard ratio; LHRH, luteinizing hormone-releasing hormone; NHIS, National Health Insurance Service; PCa, Prostate cancer; Prostate cancer; SHBG, sex hormone-binding globulin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Prostate Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google